Parodi Emilia, Giraudo Maria Teresa, Ricceri Fulvio, Aurucci Maria Luigia, Mazzone Raffaela, Ramenghi Ugo
Pediatric and Neonatology Unit, Ordine Mauriziano Hospital, Largo Turati 62, 10128 Turin, Italy.
Department of Mathematics "G. Peano", University of Turin, Via Carlo Alberto 10, 10123 Turin, Italy.
Anemia. 2016;2016:7345835. doi: 10.1155/2016/7345835. Epub 2016 Mar 22.
We report data regarding kinetic of response to oral iron in 34 iron deficiency anemia children. Twenty-four/34 patients (70.5%) reached reference value of hemoglobin (Hb) concentration for age and sex at day + 30 from the beginning of treatment (complete early responders (CERs)), and 4/34 (12%) reached an Hb concentration at least 50% higher than the original (partial early responders (PERs)). CHr at T1 (within 7 days from the beginning of treatment) was significantly different in the different groups (22.95 in CERs versus 18.41 in other patients; p = 0.001; 22.42 in early responders versus 18.07 in NERs; p = 0.001). Relative increase of CHr from T0 to T1 resulted significantly higher in CERs than in other patients (0.21 versus 0.11, p = 0.042) and in early responders than in NERs (0.22 versus 0.004, p = 0.006). Multivariate logistic models revealed a higher probability of being a complete early responder due to relative increase of ARC from T0 to T1 [OR (95% CI) = 44.95 (1.54-1311.98)] and to CHr at T1 [OR (95% CI) =3.18 (1.24-8.17)]. Our preliminary data confirm CHr as early and accurate predictor of hematological response to oral iron.
我们报告了34名缺铁性贫血儿童口服铁剂反应动力学的数据。24/34名患者(70.5%)在治疗开始后第30天达到了按年龄和性别划分的血红蛋白(Hb)浓度参考值(完全早期反应者(CERs)),4/34名患者(12%)达到的Hb浓度比初始值至少高50%(部分早期反应者(PERs))。不同组在T1(治疗开始后7天内)的网织红细胞血红蛋白含量(CHr)存在显著差异(CERs组为22.95,其他患者组为18.41;p = 0.001;早期反应者组为22.42,非早期反应者组为18.07;p = 0.001)。从T0到T1,CERs组CHr的相对增加显著高于其他患者(0.21对0.11,p = 0.042),早期反应者组高于非早期反应者组(0.22对0.004,p = 0.006)。多变量逻辑模型显示,由于从T0到T1 ARC的相对增加[比值比(95%可信区间)= 44.95(1.54 - 1311.98)]以及T1时的CHr[比值比(95%可信区间)= 3.18(1.24 - 8.17)],成为完全早期反应者的概率更高。我们初步数据证实CHr是口服铁剂血液学反应的早期且准确的预测指标。